Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1

Status

Active not recruiting 3Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Sarcoma 1Genitourinary 1

Conditions

Prostatic Neoplasms, Castration-Resistant 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Pioglitazone × 1 year × Clear all
NCT02592317 2026-06-05

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Aragon Pharmaceuticals, Inc.

Phase 1 Active not recruiting
23 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT07604779 2026-05-22

Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection

Beni-Suef University

Phase NA Active not recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT02133625 2026-03-30

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

Dana-Farber Cancer Institute

Phase 1 Completed
14 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
10 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT05919147 2025-07-04

TRACE-1

Pennington Biomedical Research Center

Phase 2 Active not recruiting
24 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡